Literature DB >> 9862562

Wild-type p53-mediated down-modulation of interleukin 15 and interleukin 15 receptors in human rhabdomyosarcoma cells.

C De Giovanni1, P Nanni, A Sacchi, S Soddu, I Manni, G D'Orazi, S Bulfone-Paus, T Pohl, L Landuzzi, G Nicoletti, F Frabetti, I Rossi, P L Lollini.   

Abstract

We recently reported that rhabdomyosarcoma cell lines express and secrete interleukin 15 (IL-15), a tightly regulated cytokine with IL-2-like activity. To test whether the p53-impaired function that is frequently found in this tumour type could play a role in the IL-15 production, wild-type p53 gene was transduced in the human rhabdomyosarcoma cell line RD (which harbours a mutated p53 gene), and its effect on proliferation and expression of IL-15 was studied. Arrest of proliferation was induced by wild-type p53; increased proportions of G1-arrested cells and of apoptotic cells were observed. A marked down-modulation of IL-15 expression, at both the mRNA and protein level, was found in p53-transduced cells. Because a direct effect of IL-15 on normal muscle cells has been reported, the presence of IL-15 membrane receptors was studied by cytofluorometric analysis. Rhabdomyosarcoma cells showed IL-15 membrane receptors, which are down-modulated by wild-type p53 transfected gene. In conclusion, wild-type p53 transduction in human rhabdomyosarcoma cells induces the down-modulation of both IL-15 production and IL-15 receptor expression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9862562      PMCID: PMC2063235          DOI: 10.1038/bjc.1998.721

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  27 in total

1.  Oncogenic forms of p53 inhibit p53-regulated gene expression.

Authors:  S E Kern; J A Pietenpol; S Thiagalingam; A Seymour; K W Kinzler; B Vogelstein
Journal:  Science       Date:  1992-05-08       Impact factor: 47.728

Review 2.  p53 and translational control.

Authors:  M E Ewen; S J Miller
Journal:  Biochim Biophys Acta       Date:  1996-03-18

3.  p53 stimulates transcription from the human transforming growth factor alpha promoter: a potential growth-stimulatory role for p53.

Authors:  T H Shin; A J Paterson; J E Kudlow
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

4.  Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma.

Authors:  L Diller; E Sexsmith; A Gottlieb; F P Li; D Malkin
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

5.  Regulation of insulin-like growth factor II P3 promotor by p53: a potential mechanism for tumorigenesis.

Authors:  L Zhang; F Kashanchi; Q Zhan; S Zhan; J N Brady; A J Fornace; P Seth; L J Helman
Journal:  Cancer Res       Date:  1996-03-15       Impact factor: 12.701

6.  Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor.

Authors:  K H Grabstein; J Eisenman; K Shanebeck; C Rauch; S Srinivasan; V Fung; C Beers; J Richardson; M A Schoenborn; M Ahdieh
Journal:  Science       Date:  1994-05-13       Impact factor: 47.728

7.  Retroviral-mediated transduction of p53 gene increases TGF-beta expression in a human glioblastoma cell line.

Authors:  T Fujiwara; T Mukhopadhyay; D W Cai; D K Morris; J A Roth; E A Grimm
Journal:  Int J Cancer       Date:  1994-03-15       Impact factor: 7.396

Review 8.  Biology and therapy of pediatric rhabdomyosarcoma.

Authors:  A S Pappo; D N Shapiro; W M Crist; H M Maurer
Journal:  J Clin Oncol       Date:  1995-08       Impact factor: 44.544

9.  Interleukin-15: a novel anabolic cytokine for skeletal muscle.

Authors:  L S Quinn; K L Haugk; K H Grabstein
Journal:  Endocrinology       Date:  1995-08       Impact factor: 4.736

10.  Redundancy of autocrine loops in human rhabdomyosarcoma cells: induction of differentiation by suramin.

Authors:  C De Giovanni; C Melani; P Nanni; L Landuzzi; G Nicoletti; F Frabetti; C Griffoni; M P Colombo; P L Lollini
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

View more
  3 in total

1.  NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human.

Authors:  Jianhua Yu; Takeki Mitsui; Min Wei; Hsiaoyin Mao; Jonathan P Butchar; Mithun Vinod Shah; Jianying Zhang; Anjali Mishra; Christopher Alvarez-Breckenridge; Xingluo Liu; Shujun Liu; Akihiko Yokohama; Rossana Trotta; Guido Marcucci; Don M Benson; Thomas P Loughran; Susheela Tridandapani; Michael A Caligiuri
Journal:  J Clin Invest       Date:  2011-04       Impact factor: 14.808

2.  DRAL is a p53-responsive gene whose four and a half LIM domain protein product induces apoptosis.

Authors:  F A Scholl; P McLoughlin; E Ehler; C de Giovanni; B W Schäfer
Journal:  J Cell Biol       Date:  2000-10-30       Impact factor: 10.539

3.  Whole genome expression profiling shows that BRG1 transcriptionally regulates UV inducible genes and other novel targets in human cells.

Authors:  Ling Zhang; Leah Nemzow; Hua Chen; Jennifer J Hu; Feng Gong
Journal:  PLoS One       Date:  2014-08-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.